Page 46 - ARNM-2-2

Advances in Radiotherapy
& Nuclear Medicine Hypofractionated radiotherapy in craniopharyngioma

doi: 10.1016/0360-3016(93)90227-m 1999;41(3):261-266.
12. Iannalfi A, Fragkandrea I, Brock J, Saran F. Radiotherapy doi: 10.1023/a:1006112600805
in craniopharyngiomas. Clin Oncol (R Coll Radiol). 21. Landolt AM, Zachmann M. Results of transsphenoidal
2013;25(11):654-667.
extirpation of craniopharyngiomas and Rathke’s cysts.
doi: 10.1016/j.clon.2013.07.005 Neurosurgery. 1991;28(3):410-415.
13. Regine WF, Mohiuddin M, Kramer S. Long-term results doi: 10.1097/00006123-199103000-00012
of pediatric and adult craniopharyngiomas treated
with combined surgery and radiation. Radiother Oncol. 22. Graffeo CS, Perry A, Link MJ, Daniels DJ. Pediatric
1993;27(1):13-21. craniopharyngiomas: A primer for the skull base surgeon.
J Neurol Surg B Skull Base. 2018;79(1):65-80.
doi: 10.1016/0167-8140(93)90039-b
doi: 10.1055/s-0037-1621738
14. Zhang C, Verma V, Lyden ER, et al. The role of definitive
radiotherapy in craniopharyngioma: A SEER analysis. Am J 23. Masson-Cote L, Masucci GL, Atenafu EG, et al. Long-term
Clin Oncol. 2018;41(8):807-812. outcomes for adult craniopharyngioma following radiation
therapy. Acta Oncol. 2013;52(1):153-158.
doi: 10.1097/COC.0000000000000378
doi: 10.3109/0284186X.2012.685525
15. Puget S, Garnett M, Wray A, et al. Pediatric
craniopharyngiomas: Classification and treatment according 24. Brown SA, Jaboin JJ, Eng TY, Bazan JG, Thomas CR Jr.
to the degree of hypothalamic involvement. J Neurosurg. Nonmalignant diseases. In: Halperin EC, Wazer DE,
2007;106(1 Suppl):3-12. Perez CA, Brady LW, editors. Perez and Brady’s Principles and
Practice of Radiation Oncology. 7 ed., Ch. 95. Philadelphia,
th
doi: 10.3171/ped.2007.106.1.3 PA: Wolters Kluwer; 2018.
16. Shi XE, Wu B, Fan T, Zhou ZQ, Zhang YL. 25. Merchant TE, Kiehna EN, Sanford RA, et al.
Craniopharyngioma: Surgical experience of 309 cases in Craniopharyngioma: The St. Jude Children’s research
China. Clin Neurol Neurosurg. 2008;110(2):151-159. hospital experience 1984-2001. Int J Radiat Oncol Biol Phys.
doi: 10.1016/j.clineuro.2007.10.013 2002;53(3):533-542.
17. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. doi: 10.1016/s0360-3016(02)02799-2
Surgical treatment of craniopharyngiomas: Experience with 26. Lee M, Kalani MY, Cheshier S, Gibbs IC, Adler JR,
168 patients. J Neurosurg. 1999;90(2):237-250. Chang SD. Radiation therapy and CyberKnife radiosurgery
doi: 10.3171/jns.1999.90.2.0237 in the management of craniopharyngiomas. Neurosurg
Focus. 2008;24(5):E4.
18. Szeifert GT, Sipos L, Horváth M, et al. Pathological
characteristics of surgically removed craniopharyngiomas: doi: 10.3171/FOC/2008/24/5/E4
Analysis of 131 cases. Acta Neurochir (Wien). 1993;124(2-4): 27. Conti A, Pontoriero A, Ghetti I, et al. Benefits of image-
139-143. guided stereotactic hypofractionated radiation therapy as
doi: 10.1007/BF01401137 adjuvant treatment of craniopharyngiomas. A review. Childs
Nerv Syst. 2019;35(1):53-61.
19. Hoffman HJ. Surgical management of craniopharyngioma.
Pediatr Neurosurg. 1994;21(Suppl 1):44-49. doi: 10.1007/s00381-018-3954-z
doi: 10.1159/000120861 28. Albano L, Losa M, Flickinger J, Mortini P, Minniti G.
Radiotherapy of parasellar tumours. Neuroendocrinology.
20. Honegger J, Grabenbauer GG, Paulus W, Fahlbusch R.
Regression of a large solid papillary craniopharyngioma 2020;110(9-10):848-858.
following fractionated external radiotherapy. J Neurooncol. doi: 10.1159/000506902

Volume 2 Issue 2 (2024) 9 doi: 10.36922/arnm.3041